News RSS Bioethics News.

04/17/2018

Drug Company ‘Shenanigans’ to Block Generics Come Under Federal Scrutiny

External Link - Source: The New York Times

Trump administration officials, seeking ways to lower drug costs, are targeting pharmaceutical companies that refuse to provide samples of their products to generic drug companies, making it impossible to create inexpensive generic copies of a brand-name medicine.

This entry was posted in Pharmaceuticals and tagged . Bookmark the permalink.